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A 69-year-old female patient with dyspnea (NYHA III), 
chest pain (CCS II), and an elevated high-sensitivity tro-
ponin I (hs-TnI) level (274 ng/l in the face of normal cre-
atinine – 78 μmol/l) was admitted to our department. 
She had a  history of arterial hypertension (max. 190/ 
140 mm Hg) and hypercholesterolemia. ECG revealed si-
nus rhythm of 75 beats per minute, ST-segment elevation 
in V2 up to 2 mm and a negative T wave in V2–V6. On 
current (three drugs) pharmacotherapy consisting of an 
angiotensin receptor blocker, a  diuretic and a  very low 
dose of metoprolol (25 mg/day), blood pressure was 
112/61 mm Hg (the relatively low value for arterial hy-
pertension was probably related to left ventricular out-
flow tract (LVOT) obstruction; see echocardiogram de-
scription below).
Echocardiography was performed prior to coronary 
angiography. Current angina pectoris, with elevated 
troponin level, ischemic signs in ECG and risk factors 
of coronary artery disease – age 69 years, smoking and 
hypertension – were arguments for the decision to per-
form coronary angiography (on the admission day, both 
echocardiography and coronary angiography were per-
formed). Echocardiography revealed significantly reduced 
left ventricle (LV) cavity size with akinesia of the apex and 
the presence of thrombus (Figure 1 A). Asymmetric LV 
hypertrophy (LV end-diastolic septal thickness of 2.0 cm) 
and severe LVOT gradient of 85 mm Hg (Figure 1 B) with 
systolic anterior movement (SAM) of mitral leaflet in 
resting condition were detected as a  common picture 
of hypertrophic cardiomyopathy (HCM) (Figure 1 C). 
Thick mitral valve leaflets are a frequent phenomenon in 
HCM as well as a early phenomenon of genotype posi-
tive but phenotype negative HCM patients. The coronary 
artery angiogram was normal in left side epicardial cor-
onary vasculature, and nearly normal with insignificant 
stenosis of the right coronary artery.
The vasodilator and diuretic were gradually decreased 
(to maximize LV preload) and were substituted by in-
creasing doses of β-blocker. Simultaneously both LVOT 
gradient and hs-TnI level decreased in day-by-day moni-
toring to normal values (Figure 1 D, final levels: hs-TnI = 
8.4 ng/l and LVOT gradient = 12 mm Hg). The time profile 
of the NT-proBNP level declined but the last measure- 
ment was still markedly above the normal value (admis-
sion – 5789 pg/ml, 3rd day – 2415 pg/ml, discharge – 
541 pg/ml). Anginal pain and dyspnea gradually de-
creased. Finally, at discharge, the patient was in NYHA 
class II, without angina pectoris, ECG changes were stable 
during hospitalization and at discharge, the latest blood 
pressure was 124/65 mm Hg (at a dose of only one drug 
– 100 mg of metoprolol). 24-hour ECG Holter monitoring, 
performed on the 2nd/3rd day when positive hs-TnI was de-
tected, revealed one very short episode of non-sustained 
ventricular tachycardia (nsVT). Neither palpitation nor 
syncope in the pre-hospitalization period was present, 
but full exclusion of nsVT without ECG (especially Holter 
monitoring just before admission) recording is unrealistic. 
The family history for sudden cardiac death was negative.
According to the third universal definition of myocar-
dial infarction, lack of ECG changes or a normal coronary 
angiogram does not exclude acute coronary syndrome 
(ACS). Our patient presented hypertrophic cardiomyop-
athy with severe LVOT obstruction as a  variant of ACS 
(type 2). Myocardial ischemia was induced by imbalance 
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between oxygen supply/demand (increased demand due 
to high LV systolic pressure, generated by significant 
LVOT gradient). The patient did not present symptoms 
and signs suggesting acute heart failure (it is important 
that a  beneficial decrease of NT-proBNP level occurred 
despite termination of the diuretic and angiotensin re-
ceptor inhibitor) or pulmonary embolism (mild tricuspid 
regurgitation, without pulmonary hypertension, normal 
sized right ventricle in echocardiography). 
As regards ventricular arrhythmia, briefly, a  single 
episode of nonsustained VT was recorded during hospi-
talization. During the remaining time of hospitalization 
continuous ECG monitoring did not reveal nsVT. Before 
admission, the patient denied palpitation of heart or syn-
cope (she was probably without an episode of nsVT/sVT).
In our opinion, elimination of drugs reducing preload 
(valsartan 160 mg and hydrochlorothiazide 12.5 mg), 
lowered afterload due to valsartan action and increasing 
doses of inotropic acting β-blocker (100 mg) are respon-
sible for LVOT gradient reduction and coincidence with 
troponin normalization. In contrast, NT-proBNP did not 
reach a  normal value. Stress echocardiography to pro-
Figure 1. A – Thrombus in left ventricle, B – left ventricular outflow tract obstruction confirmed by an echo-
cardiographic examination (full septal – leaflet contact at systole – red arrows), C – LVOT gradient 85 mm Hg, 
D – time profile of hs-TnI and left ventricular outflow tract gradient decreasing in parallel
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voke a maximal LVOT gradient was not performed due to 
the presence of apical thrombus in the LV.
The presented case shows a  relationship between 
decreasing hs-TnI level and reducing LVOT gradient. This 
suggests that an increased LVOT gradient may be partial-
ly responsible for myocardial ischemia (apart from tachy-
cardia diagnosed to be responsible for hs-TnI release in 
hypertrophic cardiomyopathy) [1, 2]. In a previous report, 
HCM patients with elevated hs-TnI levels (positive hs-
TnI test) had higher values of both resting and provoked 
LVOT gradient [3]. However, this analysis was based only 
on one measurement of LVOT gradient and hs-TnI syn-
chronized in a 24-hour period. The observation provides 
five pairs of simultaneous measurements of LVOT gra-
dient and hs-TnI at different time points, revealing the 
time-course profile of LVOT gradient and ischemic bio-
marker parameters.
Previously, in invasive studies (resting supine posi-
tion) myocardial ischemia (lactate production) corre-
sponding with an increasing LVOT gradient was induced 
by rapid atrial pacing or β-receptor stimulation [4, 5]. 
Beta-receptor stimulation increased the LVOT gradient in 
parallel with release of an ischemic biomarker, i.e., lac-
tate production [4]. In contrast, surgical decrease of the 
LVOT gradient was correlated with a beneficial shift from 
lactate production to consumption [6].
In conclusion, our case has shown that normalization 
of the LVOT gradient was in parallel with normalization of 
hs-TnI, while a high value of NT-proBNP was not reduced 
to the normal range. 
This observation, showing that hs-TnI is more related 
to LVOT gradient than NT-proBNP, supports the hypothe-
sis that ischemic markers may better reflect the risk of 
sudden cardiac death in HCM than natriuretic biomark-
ers [7].
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